January 29th 2023
By Colleen Moretti
Chemoradiotherapy may be an appropriate treatment option after surgery for patients with stage 3 endometrial cancer, especially those are a higher risk of recurrence.
January 28th 2023
By Wendy Reichental
I was shocked when I was diagnosed with a myeloproliferative neoplasm, and have dedicated myself to learning about the disease since.
January 28th 2023
By Colleen Moretti
The treatment previously demonstrated significantly improved overall survival for patients with recurrent glioblastoma in a phase 1 study.
January 27th 2023
By Colleen Moretti
The Food and Drug Administration approved Orserdu for patients with ER-positive, HER2-negative, ESR1-mutated advanced or metastatic breast cancer.
January 27th 2023
By Brielle Benyon
The Food and Drug Administration approved Jaypirca for patients with relapsed/refractory mantle cell lymphoma who have been previously treated with multiple lines of therapy.
January 27, 2023 6:00 PM
By Bonnie Annis
January 26, 2023 6:00 PM
By Natasha Carlson
January 25, 2023 6:00 PM
By William Ramshaw
January 24, 2023 6:00 PM
By Mark Hicks
January 4, 2023 4:00 PM
December 30, 2022 8:00 PM
December 30, 2022 2:00 PM
December 29, 2022 8:00 PM
January 28, 2023 7:00 PM
By Wendy Reichental
January 26, 2023 2:00 PM
By Stephanie Landon
January 25, 2023 4:00 PM
By Shoba Rao
January 23, 2023 8:00 PM
By John Smelcer, PhD, CAGS